한글목차

세계 인간 난자 동결 보존 시장의 미래는 25-30세 여성, 30-35세 여성, 35-40세 여성 시장에서의 기회로 유망시되고 있습니다. 세계의 인간 난자 동결 보존 시장은 2025-2031년에 CAGR 15%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 가임력 보존의 수요 증가, 동결 보존 기술의 성공률 상승, 생식 보조 의료 기술의 채택 증가입니다.

• Lucintel의 예측에 따르면 유형별로는 급속냉동법이 예측 기간 중 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 30-35세 여성이 가장 높은 성장이 예상됩니다.
• 지역별로는 북미가 예측 기간 중 가장 높은 성장을 보일 것으로 예측됩니다.

인간 난자 동결보존 시장의 새로운 동향

인간 난자 동결보존 시장은 기술과 채택 모두에 영향을 미치는 몇 가지 새로운 동향에 의해 재정의되고 있습니다. 이러한 추세는 사회적 규범의 변화, 생식 기술의 발전, 의료 정책의 변화를 반영하고 있습니다. 이 시장의 성장과 진화를 형성하는 5가지 주요 동향은 다음과 같습니다.

• 동결보존법 강화: 동결보존법, 특히 유리화법의 발전으로 난자 동결보존의 성공률이 크게 향상되었습니다. 유리화는 동결 중 얼음 결정 형성을 제거하여 난자의 구조적 무결성을 보호하고 생존율을 향상시켰습니다. 이 방법을 통해 난자 동결은 더욱 신뢰할 수 있고 널리 보급될 수 있게 되었습니다. 기술의 발전과 함께 냉동 보존법의 발전은 보존할 수 있는 난자의 질과 양을 증가시켜 시장을 더욱 성장시킬 것입니다.
• 인식 증가와 사회적 수용: 사회적 규범이 변화함에 따라 더 많은 여성들이 경력이나 개인적 필요를 위해 난자 보존을 선택하고 있습니다. 난자 동결보존과 그 이점에 대한 인식이 높아지면서, 특히 임신을 미루고 싶어하는 30-40대 여성들 사이에서 난자 동결보존에 대한 수요가 증가하고 있습니다. 미디어 노출과 적극적인 활동은 난자 동결을 생식 복지의 일반적인 측면으로 정상화하는 데 도움이 되고 있습니다. 보조생식술에 대한 사회적 수용성이 높아짐에 따라 전 세계에서 난자 동결 서비스에 대한 수요가 증가할 것으로 보입니다.
• 가임력 보존에 대한 보험 적용: 일부 지역에서는 보험사에서 가임력 보존 서비스를 보장하고 있으며, 난자 동결보존을 보다 경제적으로 실행 가능한 것으로 만들고 있습니다. 이러한 추세는 미국에서 가장 잘 관찰되며, 보험 적용이 불임 치료 혜택의 일부로 난자 동결을 보장하기 시작했습니다. 보험이 적용되면 더 많은 여성들이 난자 동결보존을 이용할 수 있는 경제적 여력이 생기게 됩니다.
• 인공지능과의 기술 융합: 인간 난자 동결보존에 인공지능(AI)을 통합하는 것은 새로운 동향이며, AI는 동결용 난자 선택을 극대화하고, 난자의 질을 평가하고, 배아 배양 방법을 향상시키는 데 활용되고 있습니다. AI가 불임 치료를 더욱 정확하고 효율적으로 만들면서 난자 동결보존 시장을 크게 발전시킬 것이며, 난자 동결보존 시장을 더욱 발전시킬 것입니다.
• 정책적 지원과 규제의 진화: 정책 입안자들은 불임 치료와 관련된 더 많은 가이드라인을 제공하고 있으며, 그 결과 시장의 표준화와 안전성이 향상되고 있습니다. 대부분의 국가에서 난자 동결보존의 보급을 보장하기 위한 정책 환경의 변화가 일어나고 있습니다. 각국 정부도 저출산 대책의 일환으로 가임력 보존에 대한 정책적 인센티브를 제공하기 시작했습니다. 이러한 정책적 발전은 불임 클리닉이 난자 동결보존 서비스를 시행하고 환자의 성공과 안전을 보장할 수 있는 명확한 경로를 제공합니다.

인간 난자 동결보존 시장은 동결보존 기술의 향상, 사회적 변화, 규제 당국의 지원 강화 등의 영향을 받아 혁명적인 변화를 겪고 있습니다. 기술 개발, 사회적 수용성 확대, 보험 적용 범위 확대, AI 통합, 정책 변화 등의 추세는 불임 치료의 전망에 혁명을 불러일으키고 있습니다. 이러한 추세는 시장 성장을 가속할 뿐만 아니라 난자 동결보존 서비스의 접근성, 경제성, 전반적인 성공률을 향상시키고 있습니다.

인간 난자 동결보존 시장의 최근 동향

인간 난자 동결보존 시장의 최근 동향은 주로 기술 혁신, 사회 규범의 변화, 규제 환경의 변화에 의해 영향을 받고 있습니다. 이로 인해 전 세계에서 가임력 보존법의 적용이 증가하고 있습니다. 다음 섹션에서는 시장 현황을 정의하고 있는 5가지 주요 동향을 살펴봅니다.

• 유리화 기술 개발: 유리화 동결보존은 지난 10년간의 기술로서 인간 난자 동결보존 산업을 변화시킨 기술입니다. 이 기술은 동결 중 얼음 결정의 손상으로부터 세포를 보호하고, 보존된 난자의 품질과 해동시 성공률을 향상시킵니다. 이 기술을 통해 난자 동결은 보다 효율적이고 신뢰할 수 있게 되었으며, 가임력 보존을 선택하는 여성들에게 더 나은 결과를 가져다주었습니다.
• 불임 치료 서비스 증가: 불임 치료 센터는 수요 증가에 직면하여 난자 동결보존 서비스를 더 자주 제공하게 되었습니다. 센터는 현재 경력이나 개인적 요인으로 출산을 늦추고 싶은 여성을 위한 난자 동결 패키지까지 서비스를 확장하고 있습니다. 또한 불임 치료 서비스가 점점 더 저렴하고 접근성이 높아지면서 더 많은 사람들이 난자 동결의 혜택을 누릴 수 있게 되었습니다. 이러한 성장은 특히 여성들이 불임 클리닉과 서비스를 이용할 수 있는 도시 지역에서 시장 확대에 박차를 가하고 있습니다.
• 가임력 보존에 대한 정부의 정책적 지원: 각국 정부는 저출산 문제를 해결하기 위한 국가 정책의 일환으로 가임력 보존을 지원하기 시작했습니다. 예를 들어 일본과 유럽의 일부 국가에서는 재정적 지원과 의료비 부담 경감을 통한 지원을 제공함으로써 난자 동결에 나서는 여성들을 설득하고 있습니다. 이러한 지원은 난자 동결이 생식 의료로 정상화되는 과정을 돕고, 난자 동결의 확대와 이용 가능성을 촉진하고 있습니다. 정부의 정책 변화에 따라 난자 동결보존 시장도 지속적인 성장이 예상됩니다.
• 의료 목적의 난자 동결의 중요성: 난자 동결보존은 현재 암 치료를 받고 있는 여성이나 생식 기관에 영향을 미칠 수 있는 다른 질환을 앓고 있는 여성의 가임력 유지에 도움이 되는 등 의료 목적으로 많이 시행되고 있습니다. 의료 목적의 난자 동결의 가능성이 알려지면서, 아이를 가질 수 있는 능력을 손상시킬 수 있는 치료를 받기 전에 생식 능력을 유지하기 위해 난자 동결보존을 이용하는 여성들이 늘고 있습니다. 이러한 난자 동결의 의료적 활용은 선택적 가임력 보존의 틀을 넘어 난자 동결보존 서비스 수요를 증가시키고 있습니다.
• 난자 품질 분석을 위한 AI와의 기술 통합: 냉동 난자 품질 평가에 AI를 적용하는 것은 시장의 새로운 동향이며, AI 기술은 난자의 품질을 평가하고 수정 성공 확률을 추정하기 위해 불임 클리닉에 도입되고 있습니다. 이러한 통합을 통해 최고 품질의 난자 보존을 보장함으로써 난자 동결보존을 보다 효율적이고 성공적으로 수행할 수 있으며, AI 기반 툴은 불임 치료 과정의 필수적인 부분이 되어 난자 동결보존 산업의 기술 혁신을 촉진하고 있습니다.

유리화 기술의 혁신, 서비스 선택 증가, 정부의 정책적 지원, 의료용 난자 동결의 성장, AI의 도입 등 인간 난자 동결보존 시장의 새로운 발전은 시장에 혁명을 일으키고 있습니다. 이러한 변화는 시장 확대를 촉진하고, 접근성을 높이고, 불임 치료의 성공률을 높이고, 궁극적으로 여성들이 자신의 생식 생활을 더 잘 통제할 수 있도록 하여 난자 동결보존이 대중적으로 수용될 수 있는 길을 열어주고 있습니다.

목차

제1장 개요

제2장 세계의 인간 난자 동결 보존 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 2019-2031년 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 인간 난자 동결 보존 시장 동향(2019-2024년)과 예측(2025-2031년)
• 유형별
  • 서랭법
  • 급속냉동 프로세스
• 용도별
  • 25-30세 여성
  • 30-35세 여성
  • 35-40세 여성
  • 기타

제4장 2019-2031년 지역별 시장 동향과 예측 분석

• 지역별 인간 난자 동결 보존 시장
• 북미의 인간 난자 동결 보존 시장
• 유럽의 인간 난자 동결 보존 시장
• 아시아태평양의 인간 난자 동결 보존 시장
• 기타 지역의 인간 난자 동결 보존 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별
  • 용도별
  • 지역별
• 세계의 인간 난자 동결 보존 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 인간 난자 동결 보존 시장의 능력 확대
  • 세계의 인간 난자 동결 보존 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 기업 개요

• Anova Fertility
• CCRM IVF
• Chill
• CREATE Fertility
• Extend Fertility
• HRC Fertility
• IVF Australia
• Kindbody
• London Women's Clinic
• Manchester Fertility

영문목차

The future of the global human oocyte cryopreservation market looks promising with opportunities in the 25-30 year old female, 30-35 year old female, and 35-40 year old female markets. The global human oocyte cryopreservation market is expected to grow with a CAGR of 15% from 2025 to 2031. The major drivers for this market are the rising demand for fertility preservation, the growing success rates of cryopreservation techniques, and the increasing adoption of assisted reproductive technologies.

• Lucintel forecasts that, within the type category, flash-freezing process is expected to witness higher growth over the forecast period.
• Within the application category, 30-35 year old female is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the Human Oocyte Cryopreservation Market

The human oocyte cryopreservation market is being redefined by some emerging trends that affect both technology and adoption. These trends capture changing societal norms, advances in reproductive technologies, and changing healthcare policies. Five major trends shaping the growth and evolution of this market are listed below.

• Enhanced Cryopreservation Methods: Advances in cryopreservation methods, particularly vitrification, have significantly enhanced the success rates of oocyte cryopreservation. Vitrification does away with ice crystal formation during freezing, safeguarding the structural integrity of eggs and enhancing survival rates. This method has made egg freezing more dependable and widespread, leading to its uptake. With advancing technology, advances in cryopreservation methods are bound to increase the quality and quantity of eggs that can be preserved, growing the market even further.
• Growing Awareness and Social Acceptance: With changing social norms, more and more women are opting for fertility preservation for career or individual needs. Growing awareness about oocyte cryopreservation and its advantages is driving this demand, specifically among women aged between 30 and 40 who would like to defer pregnancy. Media exposure and activism have helped normalize egg freezing as an ordinary aspect of reproductive well-being. Increased social acceptance of assisted reproductive technologies is likely to enhance the demand for egg freezing services across the world.
• Insurance Coverage for Fertility Preservation: Fertility preservation services in certain regions are becoming increasingly covered by insurance companies, which is making oocyte cryopreservation more economically viable. The trend is best observed in the United States, where insurance coverage is starting to cover egg freezing as part of fertility preservation benefits. As insurance coverage increases, a greater number of women will be financially empowered to avail themselves of oocyte cryopreservation, hence increasing market growth and making these services more accessible to a broader population.
• Technology Convergence with Artificial Intelligence: Artificial intelligence (AI) integration in the human oocyte cryopreservation procedure is a new trend. AI is being utilized to maximize egg selection for freezing, evaluate oocyte quality, and enhance embryo culture methods. AI tools have the ability to examine large databases and determine the success rates of egg freezing while enhancing the decision-making function for patients and fertility experts. As AI keeps making fertility treatment more accurate and efficient, it is bound to drive the oocyte cryopreservation market forward in a major way.
• Policy Support and Evolution of Regulation: Policy makers are providing more guidelines regarding fertility preservation, which results in increased standardization and safety for the market. In most countries, the policy environment is undergoing changes to ensure the increased popularity of oocyte cryopreservation. Governments are also starting to provide policy incentives for fertility preservation, particularly as part of initiatives to meet declining birth rates. These policy developments offer clearer channels for fertility clinics to proceed and provide oocyte cryopreservation services and ensure patient success and safety.

The human oocyte cryopreservation market is undergoing revolutionary changes, influenced by enhanced cryopreservation technologies, changing society, and increased regulatory support. Trends like developments in techniques, increased social acceptance, insurance coverage extension, integration of AI, and changing policies are revolutionizing the landscape of fertility preservation. These trends not only enhance the growth of the market but also enhance accessibility, affordability, and the overall success rates of oocyte cryopreservation services.

Recent Developments in the Human Oocyte Cryopreservation Market

Recent trends in the human oocyte cryopreservation market are mainly influenced by innovation, shifting societal norms, and altering regulatory environments. These have led to a rising application of fertility preservation methods across the world. The subsequent section identifies five major trends that are defining the market's contemporary situation.

• Developments in Vitrification Technology: Cryopreservation via vitrification, a technology of the last decade, transformed the human oocyte cryopreservation industry. The technique shields the cells against ice crystal damage during freezing and thus enhances preserved egg quality, as well as success rates when thawed, thereby becoming a widely accepted technology for freezing eggs, leading to the extensive implementation of oocyte cryopreservation. This technology has rendered egg freezing more efficient and reliable, with better results for women who opt to store their fertility.
• Increase in Fertility Preservation Services: Faced with increasing demand, fertility centers are now offering oocyte cryopreservation services more frequently. Centers are now broadening their services to include egg freezing packages for women who wish to delay childbearing as a result of career or personal factors. Besides, fertility preservation services are increasingly becoming affordable and accessible, allowing a wider population to benefit from egg freezing. This growth is fueling market expansion, especially in urban centers where women can access fertility clinics and services.
• Government Policy Support for Fertility Preservation: Governments in various nations are starting to support fertility preservation as part of national policy efforts to address shrinking birth rates. For instance, in Japan and certain European nations, lawmakers are persuading women to freeze their eggs by offering support through financial aid or reduced-cost health care alternatives. The support is aiding the process of normalizing egg freezing as a reproductive health treatment, thus encouraging its expansion and availability. With changes in government policies, the oocyte cryopreservation market is also set for continued growth.
• Greater Emphasis on Egg Freezing for Medical Purposes: Oocyte cryopreservation is now more frequently being done for medical purposes, like helping to preserve fertility for women who are receiving cancer treatment or other medical conditions that can impact the reproductive system. As word gets out about the possibility of medical egg freezing, more women are using cryopreservation to preserve their fertility before receiving treatments that can damage their ability to have children. This healthcare use of egg freezing is widening the market beyond elective fertility preservation, making increased demand for cryopreservation services.
• Integration of Technology with AI for Egg Quality Analysis: The application of AI to evaluate the quality of eggs for freezing is a new trend in the market. AI technology is being incorporated into fertility clinics to evaluate oocyte quality and estimate the probability of success upon fertilization. This integration ensures that cryopreservation becomes more efficient and successful by ensuring that eggs of the highest quality are preserved. AI-powered tools are becoming an integral part of the fertility treatment process, fueling innovation within the oocyte cryopreservation industry.

New developments within the human oocyte cryopreservation market, such as innovation in vitrification technology, increased service options, governmental policy endorsement, growth of medical egg freezing, and AI implementation, are revolutionizing the market. These changes are stimulating market expansion, increasing accessibility, and advancing fertility preservation success rates, eventually giving women more control over their reproductive life and paving the way for general acceptance of oocyte cryopreservation.

Strategic Growth Opportunities in the Human Oocyte Cryopreservation Market

The human oocyte cryopreservation market is expected to grow further as fertility preservation gains popularity and access. With increasing demand caused by shifting social norms, technological advances, and improved health care access, a number of strategic growth opportunities are arising. Below are highlights of principal opportunities for growth in the market.

• Growth in Developing Markets: Developing countries across Asia, Africa, and Latin America hold enormous growth opportunities for oocyte cryopreservation services. Due to increased awareness about fertility preservation and enhanced healthcare infrastructure, there is growing demand from women in these markets for fertility services. Clinics and healthcare providers extending into these emerging markets can fill the growing need for egg freezing services, increasing market growth.
• Collaborations with Insurance Companies: With increasing frequency in fertility preservation, collaborations between insurance companies and fertility clinics can facilitate the affordability of oocyte cryopreservation services. By integrating egg freezing in health insurance packages, providers can increase the accessibility of these services to a broader population, especially women aged in their 30s and 40s who might be considering fertility preservation due to medical or personal factors.
• Technological Advancements in Cryopreservation: Techniques Ongoing advancements in cryopreservation technologies, such as ongoing refinement of vitrification, provide expansion opportunities for businesses engaged in oocyte cryopreservation. Through investing in research and development of improved and improved cryopreservation methods, stakeholders are able to further enhance egg survival and thawing success rates, which will increase customer satisfaction and adoption of services.
• Focus on Fertility Preservation for Medical Reasons: As more people become aware of the need to preserve fertility prior to exposure to treatments such as chemotherapy, fertility clinics that provide specialized services to women who are receiving medical treatment have ample opportunity for growth. Offering cheap and accessible egg freezing for medical purposes, such as treating cancer, can allow clinics to reach a new set of patients and grow market demand for cryopreservation services.
• Integration of AI with Egg Quality: The use of AI in the integration of egg freezing services poses great growth possibilities. AI enhances the quality control of eggs frozen, thus heightening success and enhancing patient success. Fertility clinics that apply AI technology for their cryopreservation processes improve their competitive positioning and attract new patients by utilizing sophisticated, accuracy-based fertility therapy.

human oocyte cryopreservation market holds huge growth possibilities in emerging regions, collaborations with insurance companies, development in cryopreservation techniques, medical condition-based fertility preservation, and artificial intelligence integration. All these chances are likely to drive the expansion of the market through enhanced access, increased success rates, and improved patient experiences. By acting on these drivers, market participants can expand their market share as well as propel the development of fertility preservation across the globe.

Human Oocyte Cryopreservation Market Driver and Challenges

The human oocyte cryopreservation market is affected by several drivers and challenges associated with technological innovation, shifting societal perceptions, economic conditions, and regulatory changes. Although these drivers are driving the growth of the market, there are some challenges that need to be overcome for further growth. The subsequent section outlines the major drivers and challenges in the market.

The factors responsible for driving the human oocyte cryopreservation market include:

1. Cryopreservation Technologies: Advances in technologies of cryopreservation, notably vitrification, have led to improved post-thaw success rates of egg cryopreservation. These technologies enable improved quality preservation of the egg, giving rise to enhanced post-thaw success rates. Advances in the technologies of cryopreservation will be instrumental in increasing the size of the market as women feel increasingly assured regarding the dependability of egg freezing.

2. Shift in Social Norms and Postponed Childbearing: As social norms change, increasing numbers of women are postponing childbearing due to career, education, and personal preference. The increased trend of delayed marriages and childbearing, especially in developed countries, has increased the demand for fertility preservation procedures. This shift in social norms is one of the key factors driving the expansion of the oocyte cryopreservation market.

3. Greater Awareness and Accessibility: Rising awareness of fertility preservation alternatives, along with greater access to fertility clinics and treatment, is stimulating oocyte cryopreservation adoption. Greater public awareness through media campaigns, healthcare professionals, and advocacy organizations is urging more women to take egg freezing into consideration as part of their reproductive health choices.

4. Government Assistance and Fertility Policies: There is growing government assistance for fertility preservation services in many countries, and policies and measures are being made to cope with declining birth rates. Subsidized fertility preservation services or funding incentives are offered to women in some places, who are weighing the possibility of egg freezing. These policies have made fertility preservation more widely accessible to more women.

5. Fertility Preservation Demand Due to Medical Procedures: The increasing demand for fertility preservation services for women who are undergoing medical procedures, including chemotherapy, is one of the major drivers of market growth. With more medical practitioners acknowledging the need to preserve fertility in women who are receiving cancer treatment and other medical procedures, more women are freezing their eggs.

Challenges in the human oocyte cryopreservation market are:

1. Excessive Price of Oocyte Cryopreservation: Egg freezing remains very expensive and continues to present a major hindrance, especially to women lacking insurance coverage. The expense, as well as ovarian stimulation, retrieval, and storage charges, keeps many from access. Notwithstanding increased availability and affordability, price continues to keep it in reach for numerous areas.

2. Ethical and Regulatory Issues: Ethical and regulatory issues regarding assisted reproductive technologies, such as oocyte cryopreservation, still affect the market. Various nations have different regulations on the storage and utilization of frozen eggs, which can slow down market growth. Social controversies regarding the ethics of egg freezing and surrounding technologies can also affect public attitudes and regulatory policies.

3. Restricted Success Rates and Possibility of Egg Quality Degradation: Despite improvements in cryopreservation methods, thawed oocyte success rates may be variable, and egg quality will degrade over time. Women freezing eggs at an earlier age typically have higher success rates, potentially restricting the attractiveness of egg freezing for women in later life. These issues need to be addressed to drive improved market growth and patient satisfaction.

The human oocyte cryopreservation market is driven by technological advancements, changing social norms, increased awareness, government support, and medical fertility preservation demand. However, challenges related to cost, ethical concerns, and variable success rates remain significant obstacles. Addressing these challenges will be crucial for unlocking the full potential of the market and expanding accessibility for women worldwide.

List of Human Oocyte Cryopreservation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies human oocyte cryopreservation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the human oocyte cryopreservation companies profiled in this report include-

• Anova Fertility
• CCRM IVF
• Chill
• CREATE Fertility
• Extend Fertility
• HRC Fertility
• IVF Australia
• Kindbody
• London Women's Clinic
• Manchester Fertility

Human Oocyte Cryopreservation Market by Segment

The study includes a forecast for the global human oocyte cryopreservation market by type, application, and region.

Human Oocyte Cryopreservation Market by Type [Value from 2019 to 2031]:

• Slow-cooling Method
• Flash-freezing Process

Human Oocyte Cryopreservation Market by Application [Value from 2019 to 2031]:

• 25-30 Year Old Female
• 30-35 Year Old Female
• 35-40 Year Old Female
• Others

Human Oocyte Cryopreservation Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Human Oocyte Cryopreservation Market

The human oocyte cryopreservation market has witnessed immense growth over the past few years because of improvement in assisted reproductive technologies, increasing awareness of fertility preservation, and changing societal trends. Oocyte cryopreservation, or egg freezing, is increasingly being opted for by women who desire to freeze their fertility for future utilization. Advances in cryopreservation technology, policy guidelines, and ethical issues have driven the market environment of this market. Growth of the market is especially prominent in nations like the United States, China, Germany, India, and Japan, where fertility preservation is picking up pace.

• United States: Oocyte cryopreservation has been quickly adopted in the United States, particularly by women who desire to defer childbearing due to personal or professional reasons. Improvements in cryopreservation procedures, including vitrification, have dramatically increased egg survival and success rates. Fertility centers nationwide are providing egg freezing services, with an emphasis on providing cost-effective options and accessibility to a wider range of demographics. Additionally, regulatory monitoring by the FDA means that safety procedures are upheld, helping to build confidence among consumers. Oocyte cryopreservation is increasingly available via insurance reimbursement in some areas, again fueling the market growth.
• China: China's human oocyte cryopreservation market is expanding, though, albeit with distinctive challenges, given cultural attitudes towards childbearing and fertility, as well as family planning regulations. Although China's one-child policy has been relaxed, cultural expectations regarding family size and childbearing are still prevalent. However, urbanization and changing social structures have created the growing need for fertility preservation. The Chinese government has recently also endorsed egg freezing in some clinics, especially in women with health conditions that jeopardize their ability to conceive. With ongoing technology improvements in assisted reproductive technologies, China's market for oocyte cryopreservation is ready to grow in the future, primarily in major metropolitan areas.
• Germany: Germany's human oocyte cryopreservation market has been growing steadily, driven by growing acceptability for assisted reproductive technologies and shifting social attitudes towards family planning. The nation boasts a highly regulated healthcare system with high standards for fertility preservation. Although oocyte cryopreservation is easily accessible in fertility clinics, ethical and legal considerations hold substantial influence over the market. The German government's stringent laws regarding reproductive technologies, such as restrictions on the number of embryos that can be preserved, have shaped the uptake of oocyte cryopreservation, particularly among women who wish to postpone childbearing for professional or personal purposes.
• India: India's oocyte cryopreservation market is growing at a fast pace, fueled by growing awareness of fertility preservation and expanding fertility clinic coverage in urban India. Indian women, especially those in urban cities, are increasingly turning towards egg freezing thanks to shifting societal norms, delayed marriages, and the need to pursue careers. Improvements in cryopreservation technologies and more developed healthcare facilities are also allowing women to maintain their fertility. While cost still acts as a deterrent for the majority, improved affordability and availability of fertility procedures are making oocyte cryopreservation a feasible choice for women in India.
• Japan: In Japan, oocyte cryopreservation is becoming popular, particularly with women postponing childbirth because of career goals and social pressures. Japan has the lowest fertility rates in the world, and freezing eggs is perceived as a likely solution for females who wish to retain their reproductive choices. There are government policies that have been supporting fertility preservation, and improvement in cryopreservation technology has been enhancing egg freezing success. Yet, social beliefs regarding reproductive technology continue to transform, and market expansion is conditioned by cultural perspectives on children and family, coupled with regulatory complications.

Features of the Global Human Oocyte Cryopreservation Market

Market Size Estimates: Human oocyte cryopreservation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Human oocyte cryopreservation market size by type, application, and region in terms of value ($B).

Regional Analysis: Human oocyte cryopreservation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the human oocyte cryopreservation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the human oocyte cryopreservation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the human oocyte cryopreservation market by type (slow-cooling method and flash-freezing process), application (25-30 year old female, 30-35 year old female, 35-40 year old female, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Human Oocyte Cryopreservation Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Human Oocyte Cryopreservation Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Human Oocyte Cryopreservation Market by Type
  • 3.3.1: Slow-cooling Method
  • 3.3.2: Flash-freezing Process
• 3.4: Global Human Oocyte Cryopreservation Market by Application
  • 3.4.1: 25-30 Year Old Female
  • 3.4.2: 30-35 Year Old Female
  • 3.4.3: 35-40 Year Old Female
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Human Oocyte Cryopreservation Market by Region
• 4.2: North American Human Oocyte Cryopreservation Market
  • 4.2.1: North American Market by Type: Slow-cooling Method and Flash-freezing Process
  • 4.2.2: North American Market by Application: 25-30 Year Old Female, 30-35 Year Old Female, 35-40 Year Old Female, and Others
• 4.3: European Human Oocyte Cryopreservation Market
  • 4.3.1: European Market by Type: Slow-cooling Method and Flash-freezing Process
  • 4.3.2: European Market by Application: 25-30 Year Old Female, 30-35 Year Old Female, 35-40 Year Old Female, and Others
• 4.4: APAC Human Oocyte Cryopreservation Market
  • 4.4.1: APAC Market by Type: Slow-cooling Method and Flash-freezing Process
  • 4.4.2: APAC Market by Application: 25-30 Year Old Female, 30-35 Year Old Female, 35-40 Year Old Female, and Others
• 4.5: ROW Human Oocyte Cryopreservation Market
  • 4.5.1: ROW Market by Type: Slow-cooling Method and Flash-freezing Process
  • 4.5.2: ROW Market by Application: 25-30 Year Old Female, 30-35 Year Old Female, 35-40 Year Old Female, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Human Oocyte Cryopreservation Market by Type
  • 6.1.2: Growth Opportunities for the Global Human Oocyte Cryopreservation Market by Application
  • 6.1.3: Growth Opportunities for the Global Human Oocyte Cryopreservation Market by Region
• 6.2: Emerging Trends in the Global Human Oocyte Cryopreservation Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Human Oocyte Cryopreservation Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Oocyte Cryopreservation Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Anova Fertility
• 7.2: CCRM IVF
• 7.3: Chill
• 7.4: CREATE Fertility
• 7.5: Extend Fertility
• 7.6: HRC Fertility
• 7.7: IVF Australia
• 7.8: Kindbody
• 7.9: London Women's Clinic
• 7.10: Manchester Fertility